Accelerating excellence in cell & gene therapy CDMO innovation.
Quality, speed and tailored solutions — your trusted CDMO partner for gene therapy success.
Your gene therapy journey starts with CoJourney
Developing cell and gene therapy products can be complex, time-consuming and highly regulated. A strategic manufacturing partner simplifies the journey with CMC expertise, regulatory support and advanced manufacturing technologies.
At CoJourney, each member of the executive team brings more than two decades of drug manufacturing expertise. This positions CoJourney as a full-service gene therapy CDMO with strong capabilities in process development, cGMP manufacturing and analytical method development.
CoJourney’s manufacturing platforms are built around quality, speed, scalability and cost-effectiveness — supporting customers worldwide as a trusted partner throughout the gene therapy development journey.
- Plasmids
- Viral vectors (AAV / LVV)
- sgRNA
- Exosomes
- Analytical method development
- cGMP quality control testing
- CMC & regulatory support
State-of-the-art GMP manufacturing
All CoJourney GMP facilities are designed to meet FDA, EMA and NMPA standards.
Hangzhou — Manufacturing campus
- · Multi-product commercial facility for GMP plasmid & mRNA manufacturing
- · 5 independent production trains — 300+ batches / year
- · Multi-product clinical GMP viral vector facility
- · 2 viral vector trains · 200L & 500L bioreactors
Philadelphia — US Office
CoJourney Inc.
CDD Building, 206 Welsh Rd
Horsham, PA 19044 · United States
Looking for GMP manufacturing and regulatory support?
CoJourney is ready to partner with you across the cell & gene therapy value chain.